-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Biora Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2019 to Q3 2024.
- Biora Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$12.3M, a 76.4% increase year-over-year.
- Biora Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$15.4M, a 71.6% increase year-over-year.
- Biora Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$65.5M, a 2602% decline from 2022.
- Biora Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $2.62M, a 56.3% decline from 2021.
- Biora Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $5.99M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)